Condition: COVID-19 Pneumonia · COVID-19 · COVID-19 Respiratory Infection · Sponsor: Weill Medical College of Cornell University
The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.
This description comes directly from the study's public registry record.
Elizabeth Manowitz, BS · 2127462627 · elm4036@med.cornell.edu
Mahniz Reza, BA · 2127462627 · CovidHeartStudy@med.cornell.edu
Always discuss trial participation with your own doctor first.
| New York Presbyterian-Brooklyn Methodist Hospital | Brooklyn, New York, United States | Recruiting |
| New York Presbyterian Queens | New York, New York, United States | Recruiting |
| Weill Cornell Medicine/New-York Presbyterian Hospital | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05164744